Rivaroxaban for patients with intermittent claudication (2024)
Source: NEJM Evidence. Unidades: FM, IME
Assunto: ESTATÍSTICA APLICADA
ABNT
RAMACCIOTTI, Eduardo et al. Rivaroxaban for patients with intermittent claudication. NEJM Evidence, v. 3, n. 9, p. 1, 2024Tradução . . Disponível em: https://doi.org/10.1056/EVIDoa2400021. Acesso em: 21 maio 2025.APA
Ramacciotti, E., Volpiani, G. G., Britto, K. F., Agati, L. B., Ribeiro, C. M., Aguiar, V. C. R., et al. (2024). Rivaroxaban for patients with intermittent claudication. NEJM Evidence, 3( 9), 1. doi:10.1056/EVIDoa2400021NLM
Ramacciotti E, Volpiani GG, Britto KF, Agati LB, Ribeiro CM, Aguiar VCR, Paganotti A, Pereira FM, Caffaro RA, Krakauer R, Rached HRS, Fareed J, Wolosker N, Anand SS, Eikelboom JW, Chang C, Lopes RD. Rivaroxaban for patients with intermittent claudication [Internet]. NEJM Evidence. 2024 ; 3( 9): 1.[citado 2025 maio 21 ] Available from: https://doi.org/10.1056/EVIDoa2400021Vancouver
Ramacciotti E, Volpiani GG, Britto KF, Agati LB, Ribeiro CM, Aguiar VCR, Paganotti A, Pereira FM, Caffaro RA, Krakauer R, Rached HRS, Fareed J, Wolosker N, Anand SS, Eikelboom JW, Chang C, Lopes RD. Rivaroxaban for patients with intermittent claudication [Internet]. NEJM Evidence. 2024 ; 3( 9): 1.[citado 2025 maio 21 ] Available from: https://doi.org/10.1056/EVIDoa2400021